Page last updated: 2024-10-28

hexamethonium and Air Sickness

hexamethonium has been researched along with Air Sickness in 2 studies

Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Qi, R1
Su, Y1
Pan, L1
Mao, Y1
Liang, L1
Dai, Z1
Wang, J1
Cai, Y1
Uchino, M1
Ishii, K1
Kuwahara, M1
Ebukuro, S1
Tsubone, H1

Other Studies

2 other studies available for hexamethonium and Air Sickness

ArticleYear
Anti-cholinergics mecamylamine and scopolamine alleviate motion sickness-induced gastrointestinal symptoms through both peripheral and central actions.
    Neuropharmacology, 2019, 03-01, Volume: 146

    Topics: Animals; Behavior, Animal; Cats; Cholinergic Antagonists; Hexamethonium; Hypothermia, Induced; Male;

2019
Role of autonomic nervous system for development and suppression of motion sickness in Suncus murinus.
    Autonomic neuroscience : basic & clinical, 2001, Dec-10, Volume: 94, Issue:1-2

    Topics: Acetylcholine; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Animals; Atropine; Autonomic Ner

2001